Our Value Proposition

Medichem history

Our Value Proposition

Medichem´s vision is to grow as a company, with unique APIs and FDFs, while ensuring a positive customer experience. This is reflected in our value proposition to our customers and business partners:

Independently owned API and FDF
Developer and Manufacturer

Proven track record with FDA and the main
International Regulatory Agencies

Committed to On-Time Delivery and
Outstanding Quality

Supports Customers to help them
achieve their Goals


Medichem’s DNA

MEDICHEM’S DNA

For more than half a century, Medichem has been at the forefront of innovation for its two commercial entities, Chlorhexidine and Generics, and has developed 70 value-added APIs and FDFs.
Medichem strives constantly to improve its customer service. We are present in 70 countries, with sites located in Spain, Malta and China as well as in the USA.
Medichem also goes beyond its core business by offering solutions such as custom manufacturing, HPAPIs, intermediaries and patent strategy. All this while providing an unrivalled history of regulatory.


Made With Care

MADE WITH CARE, a simple promise…

Listening to our customers and the specificities of the market, it became evident that four essential qualities were valued when working with us. They have become the cornerstone of Medichem´s value proposition and continue to shape our daily activities:

Reliable

Paying attention to every step of
development, manufacturing and delivery, time and again.

Customer-Oriented

Understanding the needs of our
customers now and in the future,
as the foundation for mutual success.

Quality-driven

Aiming at the highest quality standards and with an unparalleled regulatory track record.

First to Market

Our customers´ priority, and therefore our primary supply chain objective and IP strategy.


KEY NUMBERS ABOUT MEDICHEM

Marketing authorizations

877

Marketing authorizations

Manufacturing sites

3

Manufacturing sites

Employees

440

Employees

Countries distributed

60

Countries distributed

Years in operation

50

Years in operation

Products in development

28

Products in development

Turnover share spent on R&D

14%

Turnover share spent on R&D

505(b)(2) in development

2

505(b)(2) in development

Patents and patent applications

68

Patents and patent applications

Available & unique products

62

Available & unique products